ATE471711T1 - Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen - Google Patents

Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen

Info

Publication number
ATE471711T1
ATE471711T1 AT07788135T AT07788135T ATE471711T1 AT E471711 T1 ATE471711 T1 AT E471711T1 AT 07788135 T AT07788135 T AT 07788135T AT 07788135 T AT07788135 T AT 07788135T AT E471711 T1 ATE471711 T1 AT E471711T1
Authority
AT
Austria
Prior art keywords
release
subcutaneous implants
active substance
longer period
substance over
Prior art date
Application number
AT07788135T
Other languages
English (en)
Inventor
Patrice Mauriac
Pierre Marion
Original Assignee
Mediolanum Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Pharmaceuticals Ltd filed Critical Mediolanum Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE471711T1 publication Critical patent/ATE471711T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07788135T 2006-08-02 2007-08-01 Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen ATE471711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001538A ITMI20061538A1 (it) 2006-08-02 2006-08-02 Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
PCT/EP2007/057967 WO2008015236A1 (en) 2006-08-02 2007-08-01 Subcutaneous implants releasing an active principle over an extended period of time

Publications (1)

Publication Number Publication Date
ATE471711T1 true ATE471711T1 (de) 2010-07-15

Family

ID=37776598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07788135T ATE471711T1 (de) 2006-08-02 2007-08-01 Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen

Country Status (18)

Country Link
US (1) US20100062037A1 (de)
EP (1) EP2054029B9 (de)
JP (1) JP2009545563A (de)
KR (1) KR20090048463A (de)
CN (1) CN101522170B (de)
AT (1) ATE471711T1 (de)
AU (1) AU2007280395A1 (de)
BR (1) BRPI0714820A2 (de)
CA (1) CA2659440A1 (de)
DE (1) DE602007007338D1 (de)
EA (1) EA015795B1 (de)
ES (1) ES2347716T3 (de)
HK (1) HK1131547A1 (de)
IT (1) ITMI20061538A1 (de)
MX (1) MX2009001230A (de)
PL (1) PL2054029T3 (de)
PT (1) PT2054029E (de)
WO (1) WO2008015236A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2686093C (en) 2007-04-16 2018-05-08 Corium International, Inc. Solvent-cast microneedle arrays containing active
US20090123518A1 (en) * 2007-10-18 2009-05-14 Su Il Yum Biodegradable implants with controlled bulk density
JP6327852B2 (ja) 2010-05-04 2018-05-23 コリウム インターナショナル， インコーポレイテッド 微小突起アレイを使用した副甲状腺ホルモンの経皮送達のための方法及びデバイス
WO2013019280A1 (en) * 2011-08-04 2013-02-07 Flexion Therapeutics Corticosteroids for the treatment of joint pain
AU2013364053B2 (en) 2012-12-21 2018-08-30 Corium Pharma Solutions, Inc. Microarray for delivery of therapeutic agent and methods of use
RU2674083C2 (ru) 2013-03-12 2018-12-04 Кориум Интернэшнл, Инк. Аппликаторы с микровыступами
WO2014150293A1 (en) 2013-03-15 2014-09-25 Corium International, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
CA2903459C (en) 2013-03-15 2024-02-20 Corium International, Inc. Multiple impact microprojection applicators and methods of use
US10384046B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
CN103446041B (zh) * 2013-08-27 2015-06-10 青岛东辉医药科技发展有限公司 一种亮丙瑞林缓控释药棒及其制备方法
EP3188714A1 (de) 2014-09-04 2017-07-12 Corium International, Inc. Mikrostrukturanordnung, verfahren zur herstellung und verfahren zur verwendung
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
RU2612826C1 (ru) * 2015-12-30 2017-03-13 Артур Магомедович Омаров Блок имплантата для реконструкции дефектной части альвеолярного отростка и способ реконструкции дефектной части альвеолярного отростка
DE102018127200B3 (de) * 2018-10-31 2019-07-25 Andreas Haas Implantat zum subkutanen implantieren
GB202106973D0 (en) * 2021-05-14 2021-06-30 Locate Bio Ltd Osteoconductive implant material with BMP-2 delivery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
JPH08157370A (ja) * 1994-12-06 1996-06-18 Banyu Pharmaceut Co Ltd フィナステリド含有徐放性組成物
US20030211157A1 (en) * 1996-05-06 2003-11-13 Simon David Lew Semi-sol delivery blend for water soluble molecules
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
ATE316779T1 (de) * 1997-06-04 2006-02-15 Debio Rech Pharma Sa Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
AU2004251457B2 (en) * 2003-06-26 2010-09-23 Mediolanum Pharmaceuticals Ltd. Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies

Also Published As

Publication number Publication date
DE602007007338D1 (de) 2010-08-05
US20100062037A1 (en) 2010-03-11
KR20090048463A (ko) 2009-05-13
EP2054029B1 (de) 2010-06-23
WO2008015236A1 (en) 2008-02-07
EA015795B1 (ru) 2011-12-30
CA2659440A1 (en) 2008-02-07
EP2054029B9 (de) 2011-02-02
JP2009545563A (ja) 2009-12-24
CN101522170A (zh) 2009-09-02
EP2054029A1 (de) 2009-05-06
ES2347716T3 (es) 2010-11-03
MX2009001230A (es) 2009-04-28
WO2008015236A8 (en) 2008-06-05
ITMI20061538A1 (it) 2008-02-03
CN101522170B (zh) 2013-04-24
AU2007280395A1 (en) 2008-02-07
EA200900246A1 (ru) 2009-06-30
HK1131547A1 (en) 2010-01-29
PT2054029E (pt) 2010-10-04
BRPI0714820A2 (pt) 2013-05-21
PL2054029T3 (pl) 2010-11-30

Similar Documents

Publication Publication Date Title
ATE471711T1 (de) Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen
WO2007130134A3 (en) Controlled release microparticles
NO20050419L (no) Farmasoytiske blandinger av legemidler og polymerer av halv-orden
UA111162C2 (uk) Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
WO2008098019A3 (en) Polymer formulations for delivery of bioactive agents
WO2012080383A3 (en) Personal care compositions including aqueous compositions of viscoelastic surfactants and hydrophobically modified polymers
WO2010005723A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
WO2008016528A3 (en) Drug delivery after biodegradation of the stent scaffolding
ES2422681T3 (es) Formulación de fármaco de moléculas pequeñas de liberación prolongada
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
WO2010039641A3 (en) Long term drug delivery devices with polyurethane-based polymers and their manufacture
ATE382337T1 (de) Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer
WO2007011955A3 (en) Drug-containing implants and methods of use thereof
TW200630128A (en) Active ingredient-containing silicone elastomers
AR082225A1 (es) Material compuesto polimerico con funcionalidad biocida
MX2007007099A (es) Implante formado in situ para animales.
WO2012172433A3 (en) A sustained -release composition containing a melanocortin receptor ligand as the active ingredient
MX2009001231A (es) Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido.
JP2011508791A5 (de)
AR093059A1 (es) Mezclas de polimeros bioabsorbibles
UA92604C2 (ru) Композиция стансопорфина с физиологической осмотической концентрацией и ее применение
EP2462960A3 (de) Polymer zur Steuerung der Abgabe bioaktiver Wirkstoffe und Verwendungsverfahren
MX2007001721A (es) Composiciones de alimento para mascotas que tienen una propiedad de relajacion definida.
ATE451913T1 (de) Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen
EA200800733A1 (ru) Фармацевтический хитозановый наполнитель для применения в твёрдых лекарственных формах

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2054029

Country of ref document: EP